다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

QGEN

Qiagen NV (QGEN)

Qiagen NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:QGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/13	06:05	Business Wire	QIAGEN führt KI-Erweiterung für Ingenuity Pathway Analysis zur automatisierten Interpretation biologischer Daten ein	NYSE:QGEN	Qiagen NV
2024/12/13	06:05	Business Wire	QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data	NYSE:QGEN	Qiagen NV
2024/12/06	06:05	Business Wire	QIAGEN erreicht Meilenstein: Über 1.000 platzierte EZ2 Connect-Systeme zur Probenvorbereitung treiben Laborautomatisierung voran	NYSE:QGEN	Qiagen NV
2024/12/06	06:05	Business Wire	QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation	NYSE:QGEN	Qiagen NV
2024/11/28	20:00	Business Wire	QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing	NYSE:QGEN	Qiagen NV
2024/11/28	20:00	Business Wire	QIAGEN stärkt QIAstat-Dx mit neuem Standort in Barcelona zur Wachstumsbeschleunigung bei Tests für Infektionskrankheiten und Präzisionsmedizin	NYSE:QGEN	Qiagen NV
2024/11/28	06:05	GlobeNewswire Inc.	QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis	NYSE:QGEN	Qiagen NV
2024/11/13	06:05	GlobeNewswire Inc.	QIAGEN collaborates with McGill University to advance microbiome research	NYSE:QGEN	Qiagen NV
2024/11/08	01:46	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NYSE:QGEN	Qiagen NV
2024/11/07	06:05	GlobeNewswire Inc.	QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook	NYSE:QGEN	Qiagen NV
2024/11/04	15:30	GlobeNewswire Inc.	QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics	NYSE:QGEN	Qiagen NV
2024/10/29	15:30	GlobeNewswire Inc.	QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment	NYSE:QGEN	Qiagen NV
2024/10/22	05:11	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NYSE:QGEN	Qiagen NV
2024/10/11	05:05	GlobeNewswire Inc.	QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications	NYSE:QGEN	Qiagen NV
2024/10/10	20:41	GlobeNewswire Inc.	QIAGEN N.V. to release results for Q3 2024 and hold webcast	NYSE:QGEN	Qiagen NV
2024/10/08	05:05	GlobeNewswire Inc.	Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer	NYSE:QGEN	Qiagen NV
2024/10/01	05:05	GlobeNewswire Inc.	QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology	NYSE:QGEN	Qiagen NV
2024/09/27	05:05	GlobeNewswire Inc.	QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays	NYSE:QGEN	Qiagen NV
2024/09/26	05:05	GlobeNewswire Inc.	PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples	NYSE:QGEN	Qiagen NV
2024/09/24	05:05	GlobeNewswire Inc.	QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database	NYSE:QGEN	Qiagen NV
2024/09/19	05:05	GlobeNewswire Inc.	QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform	NYSE:QGEN	Qiagen NV
2024/09/13	05:05	GlobeNewswire Inc.	QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programs	NYSE:QGEN	Qiagen NV
2024/09/12	07:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:QGEN	Qiagen NV
2024/09/05	05:05	GlobeNewswire Inc.	QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease	NYSE:QGEN	Qiagen NV
2024/09/04	05:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV
2024/08/29	05:05	GlobeNewswire Inc.	QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases	NYSE:QGEN	Qiagen NV
2024/08/07	05:05	GlobeNewswire Inc.	Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%	NYSE:QGEN	Qiagen NV
2024/08/02	10:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV
2024/08/01	05:06	GlobeNewswire Inc.	QIAGEN delivers solid performance and exceeds outlook for Q2 2024	NYSE:QGEN	Qiagen NV
2024/07/09	05:05	GlobeNewswire Inc.	QIAGEN to enhance the identification of human remains of Indigenous people and African Americans	NYSE:QGEN	Qiagen NV

검색 관련기사 보기:NYSE:QGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

BNP Paribas (QX)

Gold vs US Dollar

US Dollar vs Yen

Verizon Communications

US Dollar vs Euro

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관